1	B-RNA
,	I-RNA
25-Dihydroxyvitamin	I-RNA
D3	I-RNA
receptor	I-RNA
RNA	I-RNA
:	O
expression	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

1	O
,	O
25-Dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
]	O
induces	O
differentiation	O
and	O
inhibits	O
proliferation	O
of	O
myeloid	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
from	O
various	O
lines	O
and	O
patients	O
;	O
these	O
effects	O
are	O
probably	O
mediated	O
through	O
the	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
.	O

Little	O
is	O
known	O
of	O
expression	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
in	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

We	O
examined	O
the	O
expression	O
and	O
modulation	O
of	O
expression	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
in	O
various	O
proliferating	B-cell_type
and	I-cell_type
nonproliferating	I-cell_type
hematopoietic	I-cell_type
cells	I-cell_type
.	O

Constitutive	O
expression	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
was	O
detected	O
in	O
various	O
kinds	O
of	O
hematopoietic	B-cell_type
cells	I-cell_type
,	O
including	O
macrophages	O
and	O
activated	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
as	O
well	O
as	O
in	O
cell	O
lines	O
KG-1	B-cell_line
(	O
myeloblasts	B-cell_line
)	O
,	O
HL-60	B-cell_line
(	O
promyelocytes	B-cell_line
)	O
,	O
ML-3	B-cell_line
(	O
myelomonoblasts	B-cell_line
)	O
,	O
U937	B-cell_line
,	O
THP-1	B-cell_line
(	O
monoblasts	B-cell_line
)	O
,	O
K562	B-cell_line
(	O
erythroblasts	B-cell_line
)	O
,	O
and	O
S-LB1	B-cell_line
(	O
HTLV-1-transfected	B-cell_line
T	I-cell_line
lymphocytes	I-cell_line
)	O
.	O

Receptor	B-RNA
transcripts	I-RNA
were	O
4.6	O
kilobases	O
(	O
kb	O
)	O
,	O
and	O
no	O
variant	O
sizes	O
were	O
observed	O
.	O

All	O
cell	O
lines	O
examined	O
in	O
this	O
group	O
also	O
expressed	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptors	I-protein
.	O

Most	O
B	B-cell_line
lymphocyte	I-cell_line
lines	I-cell_line
expressed	O
negligible	O
levels	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
and	O
protein	O
;	O
however	O
;	O
analysis	O
of	O
a	O
lymphoid/myeloid	B-cell_line
somatic	I-cell_line
hybrid	I-cell_line
suggested	O
that	O
suppression	O
of	O
expression	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
in	O
B	B-cell_type
lymphocytes	I-cell_type
may	O
be	O
a	O
dominant	O
characteristic	O
.	O

HL-60	B-cell_line
cells	I-cell_line
were	O
cultured	O
with	O
10	O
(	O
-7	O
)	O
mol/L	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
for	O
24	O
to	O
72	O
hours	O
,	O
and	O
levels	O
of	O
expression	O
of	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
and	O
its	O
RNA	O
were	O
examined	O
.	O

Levels	O
of	O
RNA	O
coding	O
for	O
the	O
receptor	B-protein
were	O
not	O
modulated	O
by	O
exposure	O
to	O
high	O
levels	O
of	O
ligand	O
.	O

Levels	O
of	O
occupied	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
protein	I-protein
increased	O
in	O
these	O
HL-60	B-cell_line
cells	I-cell_line
;	O
but	O
the	O
total	O
number	O
of	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptors	I-protein
decreased	O
about	O
50	O
%	O
at	O
24	O
hours	O
and	O
returned	O
toward	O
normal	O
at	O
72	O
hours	O
.	O

Steady-state	O
levels	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
were	O
not	O
affected	O
by	O
terminal	O
differentiation	O
of	O
HL-60	B-cell_line
toward	O
either	O
granulocytes	B-cell_type
or	O
macrophages	B-cell_type
.	O

Nondividing	O
macrophages	B-cell_type
from	O
normal	O
individuals	O
also	O
expressed	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
.	O

In	O
contrast	O
,	O
nondividing	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
from	O
normal	O
individuals	O
did	O
not	O
express	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
;	O
with	O
stimulation	O
of	O
proliferation	O
of	O
these	O
cells	O
,	O
accumulation	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
increased	O
markedly	O
.	O

Half-life	O
(	O
t1/2	O
)	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
in	O
T	B-cell_type
lymphocytes	I-cell_type
was	O
short	O
(	O
1	O
hour	O
)	O
as	O
determined	O
by	O
measuring	O
decay	O
of	O
the	O
message	O
after	O
addition	O
of	O
actinomycin	O
D	O
.	O

Consistent	O
with	O
this	O
short	O
t1/2	O
,	O
accumulation	O
of	O
1	B-RNA
,	I-RNA
25	I-RNA
(	I-RNA
OH	I-RNA
)	I-RNA
2D3	I-RNA
receptor	I-RNA
RNA	I-RNA
increased	O
in	O
cells	O
as	O
their	O
protein	O
synthesis	O
was	O
inhibited	O
.	O

Further	O
studies	O
are	O
required	O
to	O
understand	O
the	O
physiologic	O
role	O
of	O
1	B-protein
,	I-protein
25	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptors	I-protein
in	O
myeloid	B-cell_type
cells	I-cell_type
and	O
proliferating	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
Receptor	NULL
RNA	NULL
:	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
By	NULL
Masahiro	NULL
Kizaki	NULL
,	NULL
Anthony	NULL
W.	NULL
Norman	NULL
,	NULL
June	NULL
E.	NULL
Bishop	NULL
,	NULL
Chi-Whei	NULL
Lin	NULL
,	NULL
Amitabha	NULL
Karmakar	NULL
,	NULL
and	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
}	NULL
)	NULL
,	NULL
D	NULL
,	NULL
]	NULL
induces	NULL
differentiation	NULL
and	NULL
inhibits	NULL
proliferation	NULL
of	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
from	NULL
various	NULL
lines	NULL
and	NULL
patients	NULL
;	NULL
these	NULL
effects	NULL
are	NULL
probably	NULL
mediated	NULL
through	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
expression	NULL
and	NULL
modulation	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
receptor	NULL
RNA	NULL
in	NULL
various	NULL
proliferating	NULL
and	NULL
nonproliferating	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
detected	NULL
in	NULL
various	NULL
kinds	NULL
of	NULL
hematopoietic	NULL
cells	NULL
,	NULL
including	NULL
macrophages	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
cell	NULL
lines	NULL
KG-1	NULL
(	NULL
{	NULL
myelo-blasts	NULL
}	NULL
,	NULL
HL-60	NULL
{	NULL
promyelocytes	NULL
]	NULL
,	NULL
ML-3	NULL
(	NULL
{	NULL
myelomonoblasts	NULL
)	NULL
,	NULL
U937	NULL
,	NULL
THP-1	NULL
(	NULL
monoblasts	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
erythroblasts	NULL
)	NULL
,	NULL
and	NULL
S-LB1	NULL
(	NULL
HTLV-1-transfected	NULL
T	NULL
lymphocytes	NULL
)	NULL
.	NULL

Receptor	NULL
transcripts	NULL
were	NULL
4.6	NULL
kilobases	NULL
(	NULL
kb	NULL
)	NULL
,	NULL
and	NULL
no	NULL
variant	NULL
sizes	NULL
were	NULL
observed	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
examined	NULL
in	NULL
this	NULL
group	NULL
also	NULL
expressed	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
}	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
.	NULL

Most	NULL
B	NULL
lymphocyte	NULL
lines	NULL
expressed	NULL
negligible	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
;	NULL
however	NULL
;	NULL
analysis	NULL
of	NULL
a	NULL
lymphoid/myeloid	NULL
somatic	NULL
hybrid	NULL
suggested	NULL
that	NULL
suppression	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
B	NULL
lymphocytes	NULL
may	NULL
be	NULL
a	NULL
dominant	NULL
character-istic	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
10~	NULL
'	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
24	NULL
to	NULL
72	NULL
hours	NULL
,	NULL
and	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
TAMIN	NULL
D	NULL
,	NULL
IS	NULL
A	NULL
SECOSTEROID	NULL
;	NULL
sequential	NULL
hydrox-	NULL
ylation	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
kidney	NULL
converts	NULL
it	NULL
to	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
]	NULL
,	NULL
which	NULL
is	NULL
the	NULL
active	NULL
form	NULL
,	NULL
principally	NULL
involved	NULL
in	NULL
calcium	NULL
homeostasis	NULL
.	NULL
``	NULL

The	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
facilitates	NULL
calcium	NULL
absorption	NULL
from	NULL
the	NULL
in-testine	NULL
,	NULL
acts	NULL
to	NULL
mobilize	NULL
calcium	NULL
from	NULL
bone	NULL
,	NULL
and	NULL
stimulates	NULL
renal	NULL
reabsorption	NULL
of	NULL
calcium	NULL
.	NULL

Studies	NULL
suggest	NULL
that	NULL
this	NULL
active	NULL
metabolite	NULL
may	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
as	NULL
an	NULL
immunohematopoietic	NULL
regulatory	NULL
hormone	NULL
.	NULL
``	NULL

The	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
can	NULL
induce	NULL
cells	NULL
from	NULL
both	NULL
the	NULL
murine	NULL
myeloid	NULL
leukemia	NULL
line	NULL
(	NULL
M-1	NULL
)	NULL
Â°	NULL
and	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
``	NULL
*	NULL
to	NULL
differentiate	NULL
to	NULL
monocyte/macrophage-like	NULL
cells	NULL
.	NULL

We	NULL
previously	NULL
suggested	NULL
that	NULL
differentiation	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
intracellular	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL

The	NULL
receptor	NULL
is	NULL
an	NULL
intracellular	NULL
polypeptide	NULL
that	NULL
selectively	NULL
binds	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
with	NULL
high	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Center	NULL
for	NULL
Health	NULL
Sciences	NULL
and	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medi-cine	NULL
,	NULL
Los	NULL
Angeles	NULL
;	NULL
and	NULL
Division	NULL
of	NULL
Biomedical	NULL
Sciences	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Riverside	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
April	NULL
11	NULL
,	NULL
1990	NULL
;	NULL
accepted	NULL
November	NULL
19	NULL
,	NULL
1990	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
US	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
especially	NULL
Grant	NULL
No	NULL
.	NULL

CA	NULL
43277-3	NULL
,	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
the	NULL
Weisz	NULL
Family	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Marilyn	NULL
Levine	NULL
and	NULL
Erwin	NULL
Epstein	NULL
Memorial	NULL
Fund	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Dr	NULL
Masahiro	NULL
Kizaki	NULL
,	NULL
UCLA	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Center	NULL
for	NULL
Health	NULL
Science	NULL
,	NULL
11-240	NULL
Factor	NULL
Building	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90024	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1991	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/91/7706-0023	NULL
$	NULL
3.00/0	NULL
1238	NULL
receptor	NULL
and	NULL
its	NULL
RNA	NULL
were	NULL
examined	NULL
.	NULL

Levels	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
the	NULL
receptor	NULL
were	NULL
not	NULL
modulated	NULL
by	NULL
exposure	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
ligand	NULL
.	NULL

Levels	NULL
of	NULL
occupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
protein	NULL
increased	NULL
in	NULL
these	NULL
HL-60	NULL
cells	NULL
;	NULL
but	NULL
the	NULL
total	NULL
number	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
decreased	NULL
about	NULL
50	NULL
%	NULL
at	NULL
24	NULL
hours	NULL
and	NULL
returned	NULL
toward	NULL
normal	NULL
at	NULL
72	NULL
hours	NULL
.	NULL

Steady-state	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
terminal	NULL
differentiation	NULL
of	NULL
HL-60	NULL
toward	NULL
either	NULL
granulocytes	NULL
or	NULL
macrophages	NULL
.	NULL

Nondividing	NULL
macrophages	NULL
from	NULL
normal	NULL
individuals	NULL
also	NULL
expressed	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
nondividing	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
from	NULL
normal	NULL
individuals	NULL
did	NULL
not	NULL
express	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
;	NULL
with	NULL
stimulation	NULL
of	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
,	NULL
accumulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
increased	NULL
markedly	NULL
.	NULL

Half-life	NULL
(	NULL
t	NULL
%	NULL
)	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
T	NULL
lymphocytes	NULL
was	NULL
short	NULL
(	NULL
1	NULL
hour	NULL
)	NULL
as	NULL
determined	NULL
by	NULL
measuring	NULL
decay	NULL
of	NULL
the	NULL
message	NULL
after	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
Consistent	NULL
with	NULL
this	NULL
short	NULL
t	NULL
%	NULL
,	NULL
accumulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
increased	NULL
in	NULL
cells	NULL
as	NULL
their	NULL
protein	NULL
synthesis	NULL
was	NULL
inhibited	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
understand	NULL
the	NULL
physiologic	NULL
role	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
myeloid	NULL
cells	NULL
and	NULL
proliferating	NULL
T	NULL
lymphocytes	NULL
.	NULL

Â©	NULL
1991	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

affinity	NULL
and	NULL
interacts	NULL
with	NULL
hormone-sensitive	NULL
genes	NULL
to	NULL
produce	NULL
a	NULL
biologic	NULL
effect	NULL
.	NULL
``	NULL

''	NULL
Recently	NULL
,	NULL
cDNA	NULL
clones	NULL
encoding	NULL
chicken	NULL
,	NULL
rat	NULL
,	NULL
and	NULL
human	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptors	NULL
were	NULL
isolated	NULL
and	NULL
characterized	NULL
as	NULL
members	NULL
of	NULL
the	NULL
steroid/thyroid	NULL
hormone	NULL
receptor	NULL
family	NULL
.	NULL
``	NULL

''	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
range	NULL
of	NULL
expression	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
in	NULL
various	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
determined	NULL
basic	NULL
characteristics	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Comparison	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
number	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
made	NULL
in	NULL
several	NULL
experiments	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

-	NULL
A	NULL
variety	NULL
of	NULL
human	NULL
hematopoietic	NULL
cells	NULL
was	NULL
examined	NULL
for	NULL
expression	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
.	NULL

Leukemia	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
KG-1	NULL
(	NULL
myeloblasts	NULL
)	NULL
,	NULL
HL-60	NULL
(	NULL
promyelocytes	NULL
)	NULL
,	NULL
ML-3	NULL
(	NULL
early	NULL
myelomonoblasts	NULL
)	NULL
,	NULL
THP-1	NULL
and	NULL
U937	NULL
(	NULL
monoblasts	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
early	NULL
myeloid/erythroid	NULL
blast	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
S-LB1	NULL
(	NULL
T-lymphoid	NULL
line	NULL
immortalized	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
HTLV-1	NULL
)	NULL
.	NULL
``	NULL

B-lymphocyte	NULL
lines	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
Daudi	NULL
(	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
)	NULL
,	NULL
Dutko	NULL
(	NULL
hybrid	NULL
cell	NULL
line	NULL
between	NULL
Daudi	NULL
and	NULL
K562	NULL
cells	NULL
that	NULL
contains	NULL
the	NULL
full	NULL
complement	NULL
of	NULL
both	NULL
parental	NULL
chromosomes	NULL
)	NULL
,	NULL
Plant	NULL
(	NULL
human	NULL
B-lymphoma	NULL
cells	NULL
)	NULL
,	NULL
Jiyoye	NULL
(	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
)	NULL
,	NULL
CBL-3	NULL
[	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-positive	NULL
B-cell	NULL
line	NULL
established	NULL
from	NULL
human	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
cultured	NULL
with	NULL
MOLT	NULL
4f	NULL
superna-tant	NULL
in	NULL
serum-free	NULL
medium	NULL
]	NULL
,	NULL
HCLL-7876	NULL
(	NULL
hairy	NULL
cell	NULL
leukemia	NULL
B	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
BV173	NULL
(	NULL
B	NULL
lymphocytes	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
lymphoid	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
)	NULL
.	NULL

Plant	NULL
cells	NULL
were	NULL
established	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

CBL-3	NULL
and	NULL
HCLL-7876	NULL
cells	NULL
were	NULL
gifts	NULL
from	NULL
Dr	NULL
C.	NULL
Uittenbogaart	NULL
(	NULL
UCLA	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL
)	NULL

;	NULL
Daudi	NULL
and	NULL
Dutko	NULL
cells	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
G.	NULL
Klein	NULL
(	NULL
Stockholm	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Lu-CSF-1	NULL
is	NULL
a	NULL
cell	NULL
line	NULL
of	NULL
human	NULL
adenocarcinoma	NULL
of	NULL
lung	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
e-medium	NULL
(	NULL
Flow	NULL
Laboratories	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
,	NULL
Irvine	NULL
Scientific	NULL
,	NULL
Santa	NULL
Ana	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
77	NULL
,	NULL
No	NULL
6	NULL
(	NULL
March	NULL
15	NULL
)	NULL
,	NULL
1991	NULL
:	NULL
pp	NULL
1238-1247	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-DIHYDROXYVITAMIN	NULL
D	NULL
,	NULL
RECEPTOR	NULL
RNA	NULL
Mononuclear	NULL
blood	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
Phar-macia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
density	NULL
separation	NULL
from	NULL
heparinized	NULL
venous	NULL
blood	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
after	NULL
they	NULL
gave	NULL
informed	NULL
consent	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
washed	NULL
several	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

Macrophages	NULL
were	NULL
removed	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
adhere	NULL
by	NULL
culturing	NULL
cells	NULL
on	NULL
plastic	NULL
dishes	NULL
for	NULL
3	NULL
hours	NULL
.	NULL

The	NULL
nonadherent	NULL
mononuclear	NULL
fraction	NULL
contained	NULL
>	NULL
90	NULL
%	NULL
lymphocytes	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
light	NULL
microscopy	NULL
of	NULL
Wright-Giemsa-stained	NULL
slide	NULL
preparations	NULL
.	NULL

The	NULL
adherent	NULL
cells	NULL
were	NULL
>	NULL
95	NULL
%	NULL
macrophages	NULL
as	NULL
determined	NULL
by	NULL
morphologic	NULL
examination	NULL
using	NULL
light	NULL
microscopy	NULL
of	NULL
Wright-Giemsa-stained	NULL
slides	NULL
and	NULL
by	NULL
positive	NULL
staining	NULL
with	NULL
Â«	NULL
-naphtyl	NULL
butyrate	NULL
esterase	NULL
.	NULL

Induction	NULL
of	NULL
differentiation	NULL
was	NULL
measured	NULL
both	NULL
by	NULL
morphology	NULL
of	NULL
Giemsa-stained	NULL
cytospin	NULL
preparations	NULL
and	NULL
by	NULL
nitroblue	NULL
tetra-zolium	NULL
(	NULL
NBT	NULL
)	NULL
.	NULL

*	NULL
For	NULL
NBT	NULL
,	NULL
cell	NULL
suspension	NULL
(	NULL
2	NULL
x	NULL
10Â°	NULL
cells/mL	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
solution	NULL
containing	NULL
1.25	NULL
mg/mL	NULL
NBT	NULL
(	NULL
Sigma	NULL
Chemical	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
17	NULL
mg/mL	NULL
bovine	NULL
albumin	NULL
and	NULL
1	NULL
mg/mL	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37Â°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
cytocentri-fuged	NULL
,	NULL
fixed	NULL
in	NULL
methanol	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
safranin	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Chemicals	NULL
and	NULL
cellular	NULL
differentiation	NULL
.	NULL

|	NULL
The	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
,	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Uskokovic	NULL
(	NULL
Hoffman-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10~	NULL
mol/L	NULL
and	NULL
stored	NULL
at	NULL
-20Â°C	NULL
;	NULL
the	NULL
final	NULL
test	NULL
concentration	NULL
was	NULL
10~	NULL
'	NULL
mol/L	NULL
.	NULL

None	NULL
of	NULL
the	NULL
cultures	NULL
contained	NULL
>	NULL
0.1	NULL
%	NULL
ethanol	NULL
,	NULL
which	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
cellular	NULL
growth	NULL
or	NULL
differentiation	NULL
.	NULL

All-frans-retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
ethanol	NULL
(	NULL
10~	NULL
mol/L	NULL
)	NULL
,	NULL
stored	NULL
at	NULL
-20Â°C	NULL
,	NULL
and	NULL
protected	NULL
from	NULL
light	NULL
;	NULL
the	NULL
final	NULL
test	NULL
concentrations	NULL
were	NULL
10~	NULL
``	NULL
mol/L	NULL
.	NULL

Dimethylsulfoxide	NULL
(	NULL
DMSO	NULL
,	NULL
Sigma	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1.25	NULL
%	NULL
.	NULL

TPA	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
acetone	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10~	NULL
mol/L	NULL
,	NULL
stored	NULL
at	NULL
-70Â°C	NULL
,	NULL
and	NULL
tested	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10Â°	NULL
mol/L	NULL
.	NULL

HL-60	NULL
cells	NULL
can	NULL
differentiate	NULL
terminally	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
``	NULL
;	NULL
after	NULL
4	NULL
days	NULL
of	NULL
exposure	NULL
to	NULL
either	NULL
DMSO	NULL
(	NULL
1.25	NULL
%	NULL
)	NULL
or	NULL
RA	NULL
(	NULL
107	NULL
mol/L	NULL
)	NULL
,	NULL
~70	NULL
%	NULL
and	NULL
80	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
HL-60	NULL
cells	NULL
matured	NULL
toward	NULL
granulocyte-like	NULL
cells	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
morphology	NULL
and	NULL
ability	NULL
to	NULL
reduce	NULL
NBT	NULL
.	NULL

HL-60	NULL
cells	NULL
also	NULL
can	NULL
differentiate	NULL
along	NULL
the	NULL
macrophage	NULL
path-way*	NULL
``	NULL
;	NULL
exposure	NULL
to	NULL
either	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
(	NULL
10~	NULL
``	NULL
mol/L	NULL
)	NULL
or	NULL
TPA	NULL
(	NULL
107	NULL
mol/L	NULL
)	NULL
for	NULL
4	NULL
days	NULL
induced	NULL
~85	NULL
%	NULL
and	NULL
95	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
differentiate	NULL
toward	NULL
morphologic	NULL
and	NULL
functional	NULL
macrophage-like	NULL
cells	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
positive	NULL
staining	NULL
with	NULL
a-naphtyl	NULL
butyrate	NULL
esterase	NULL
.	NULL

Actinomycin	NULL
D	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
1	NULL
mg/mL	NULL
.	NULL

Cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Recombinant	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
(	NULL
5.6	NULL
x	NULL
10	NULL
'	NULL
U/mg	NULL
protein	NULL
)	NULL
and	NULL
recombinant	NULL
lymphotoxin	NULL
(	NULL
LT	NULL
)	NULL
(	NULL
2	NULL
x	NULL
10Â°	NULL
U/mg	NULL
protein	NULL
)	NULL
were	NULL
supplied	NULL
by	NULL
Genentech	NULL
(	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
Dr	NULL
M.	NULL
Shepard	NULL
)	NULL
.	NULL

Specific	NULL
activity	NULL
of	NULL
each	NULL
was	NULL
assayed	NULL
by	NULL
examining	NULL
cytolytic	NULL
activity	NULL
on	NULL
actinomycin	NULL
D-treated	NULL
L929	NULL
fibroblasts	NULL
.	NULL
``	NULL

RNA	NULL
isolation	NULL
and	NULL
blotting	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
by	NULL
hot	NULL
phenol	NULL
extraction	NULL
.	NULL
``	NULL

Cytoplasmic	NULL
RNA	NULL
of	NULL
lymphocytes	NULL
was	NULL
isolated	NULL
by	NULL
phenol-chloroform	NULL
extraction	NULL
.	NULL
``	NULL

Poly-A*	NULL
'	NULL
RNA	NULL
was	NULL
obtained	NULL
by	NULL
oligo-dT	NULL
cellulose	NULL
chromatography	NULL
.	NULL

Thirty	NULL
micrograms	NULL
total	NULL
cellular	NULL
RNA	NULL
or	NULL
3	NULL
pug	NULL
poly-A*	NULL
RNA	NULL
were	NULL
electrophoresed	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
,	NULL
Gaithersberg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
ICN	NULL
;	NULL
Biomedicals	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
labeled	NULL
probes	NULL
were	NULL
hybridized	NULL
for	NULL
16	NULL
to	NULL
24	NULL
hours	NULL
at	NULL
42Â°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2	NULL
x	NULL
SSC	NULL
(	NULL
1	NULL
x	NULL
SSC	NULL
=	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
15	NULL
mmol/L	NULL
sodium	NULL
citrate	NULL
,	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
to	NULL
stringency	NULL
of	NULL
0.1	NULL
x	NULL
SSC	NULL
at	NULL
65Â°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
film	NULL
.	NULL

Autoradiograms	NULL
were	NULL
exposed	NULL
for	NULL
24	NULL
hours	NULL
to	NULL
7	NULL
days	NULL
.	NULL

Modulation	NULL
in	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
quantified	NULL
by	NULL
initial	NULL
standardization	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
B-actin-specific	NULL
tran	NULL
1239	NULL
scripts	NULL
.	NULL

The	NULL
relative	NULL
density	NULL
of	NULL
B-actin-~specific	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor-specific	NULL
transcripts	NULL
in	NULL
the	NULL
different	NULL
lanes	NULL
was	NULL
first	NULL
determined	NULL
by	NULL
laser	NULL
densitometry	NULL
using	NULL
multiple	NULL
exposures	NULL
of	NULL
blots	NULL
,	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor/B-actin	NULL
in	NULL
the	NULL
control	NULL
lane	NULL
was	NULL
assigned	NULL
as	NULL
the	NULL
baseline	NULL
level	NULL
.	NULL

The	NULL
fold-stimulation	NULL
in	NULL
the	NULL
experimental	NULL
lanes	NULL
was	NULL
calculated	NULL
by	NULL
multiplying	NULL
the	NULL
ratio	NULL
of	NULL
density	NULL
of	NULL
(	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor/B-actin	NULL
)	NULL
transcripts	NULL
by	NULL
the	NULL
reciprocal	NULL
of	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
baseline	NULL
level	NULL
.	NULL

A	NULL
human	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
cDNA	NULL
probe	NULL
(	NULL
EcoRI-Pstl	NULL
,	NULL
1.1	NULL
kb	NULL
)	NULL
was	NULL
purified	NULL
from	NULL
plasmid	NULL
pGEM-7Zf	NULL
(	NULL
+	NULL
)	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
J.W	NULL
.	NULL

Pike	NULL
)	NULL
.	NULL
``	NULL

The	NULL
B-actin	NULL
probe	NULL
was	NULL
EcoRI-BamHI	NULL
(	NULL
0.7	NULL
kb	NULL
)	NULL
fragment	NULL
from	NULL
plasmid	NULL
pHF	NULL
A-3'ut	NULL
.	NULL
``	NULL

These	NULL
probes	NULL
were	NULL
P-labeled	NULL
by	NULL
random	NULL
priming	NULL
.	NULL
``	NULL

To	NULL
examine	NULL
stability	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
S-LB1	NULL
cells	NULL
that	NULL
were	NULL
exposed	NULL
to	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
for	NULL
0.25	NULL
to	NULL
8	NULL
hours	NULL
.	NULL

Actinomycin	NULL
D	NULL
at	NULL
5	NULL
ug/mL	NULL
blocked	NULL
>	NULL
95	NULL
%	NULL
total	NULL
RNA	NULL
synthesis	NULL
in	NULL
S-LB1	NULL
cells	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
``	NULL
C-uridine	NULL
incorporation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
more	NULL
than	NULL
90	NULL
%	NULL
throughout	NULL
these	NULL
experiments	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
in	NULL
regulation	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
20	NULL
pg/mL	NULL
CHX	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
.	NULL

Protein	NULL
synthesis	NULL
in	NULL
cells	NULL
cultured	NULL
with	NULL
CHX	NULL
was	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
that	NULL
of	NULL
untreated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
binding	NULL
assays	NULL
.	NULL

For	NULL
saturation	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
normal	NULL
saline	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
homogenized	NULL
in	NULL
a	NULL
glass	NULL
Teflon	NULL
Potter-Elvehjem	NULL
homogenizer	NULL
in	NULL
TED	NULL
(	NULL
10	NULL
mmol	NULL
Tris	NULL
,	NULL
1.5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
)	NULL
at	NULL
~7	NULL
x	NULL
10	NULL
'	NULL
cells/mL	NULL
;	NULL
100	NULL
pL	NULL
of	NULL
this	NULL
homogenate	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
with	NULL
varying	NULL
concentrations	NULL
(	NULL
0.5	NULL
to	NULL
6.0	NULL
nm	NULL
)	NULL
of	NULL
'	NULL
H-~1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
in	NULL
10	NULL
pl	NULL
ethanol	NULL
either	NULL
with	NULL
or	NULL
without	NULL
500-fold	NULL
excess	NULL
nonradioactive	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
.	NULL

After	NULL
4	NULL
hours	NULL
,	NULL
receptor-bound	NULL
[	NULL
Â°H	NULL
]	NULL
-1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
was	NULL
separated	NULL
from	NULL
free	NULL
'	NULL
H-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
with	NULL
hydroxylapatite	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

For	NULL
receptor	NULL
quantitation	NULL
,	NULL
an	NULL
exchange	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
10~	NULL
'	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
homogenized	NULL
as	NULL
for	NULL
saturation	NULL
analysis	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
assayed	NULL
for	NULL
occupied	NULL
and	NULL
unoccupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptors	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
previously	NULL
.	NULL
``	NULL

Cellular	NULL
incorporation	NULL
of	NULL
radioactive	NULL
thymidine	NULL
,	NULL
uridine	NULL
,	NULL
and	NULL
methio-nine	NULL
.	NULL

HL-60	NULL
cells	NULL
or	NULL
either	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
or	NULL
macrophages	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
Ci	NULL
of	NULL
either	NULL
'	NULL
H-thymidine	NULL
,	NULL
``	NULL
C-uridine	NULL
,	NULL
or	NULL
100	NULL
pCi	NULL
*	NULL
S-methionine	NULL
for	NULL
4	NULL
hours	NULL
at	NULL
37Â°C	NULL
;	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
.	NULL

Cellular	NULL
RNA	NULL
,	NULL
DNA	NULL
,	NULL
and	NULL
protein	NULL
were	NULL
precipitated	NULL
in	NULL
5	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
(	NULL
TCA	NULL
,	NULL
30	NULL
mmol/L	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
)	NULL
at	NULL
4Â°C	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
filtered	NULL
onto	NULL
glass	NULL
microfilter	NULL
membranes	NULL
(	NULL
Whatman	NULL
,	NULL
Hillsborg	NULL
,	NULL
OR	NULL
)	NULL
,	NULL
washed	NULL
in	NULL
3	NULL
%	NULL
TCA	NULL
(	NULL
30	NULL
mmol/L	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
)	NULL
,	NULL
and	NULL
heated	NULL
at	NULL
80Â°C	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

Radioactivity	NULL
was	NULL
counted	NULL
in	NULL
a	NULL
liquid	NULL
scintiflation	NULL
counter	NULL
.	NULL

RESULTS	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
are	NULL
expressed	NULL
in	NULL
most	NULL
human	NULL
hematopoietic	NULL
lines	NULL
except	NULL
B-lymphoid	NULL
cells	NULL
.	NULL

We	NULL
examined	NULL
accumulation	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
cells	NULL
from	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
blocked	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
detected	NULL
in	NULL
each	NULL
myeloid	NULL
cell	NULL
line	NULL
(	NULL
KG-1	NULL
,	NULL
HL-60	NULL
,	NULL
ML-3	NULL
,	NULL
THP-1	NULL
,	NULL
U937	NULL
,	NULL
K562	NULL
)	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

U937	NULL
,	NULL
HL-60	NULL
,	NULL
KG-1	NULL
,	NULL
and	NULL
S-LB1	NULL
(	NULL
T-cell	NULL
line	NULL
]	NULL
cells	NULL
had	NULL
especially	NULL
prominent	NULL
accumulation	NULL
of	NULL
receptor	NULL
RNA	NULL
.	NULL

Transcripts	NULL
were	NULL
4.6	NULL
kb	NULL
,	NULL
and	NULL
no	NULL
variant	NULL
sizes	NULL
were	NULL
observed	NULL
in	NULL
any	NULL
cell	NULL
type	NULL
.	NULL

Because	NULL
in	NULL
preliminary	NULL
experi-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1240	NULL
U937	NULL
THP	NULL
-1	NULL
Dutko	NULL
Daudi	NULL
Plant	NULL
2.1	NULL
kb	NULL
207	NULL
15	NULL
<	NULL
10	NULL
=	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
}	NULL
,	NULL
BOUND	NULL
(	NULL
fmol/10Scells	NULL
)	NULL
aat	NULL
[	NULL
~	NULL
S	NULL
*A	NULL
D	NULL
7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Â§	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
2	NULL
[	NULL
Â§	NULL
(	NULL
nM	NULL
)	NULL
o	NULL
ments	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
BV173	NULL
(	NULL
B-lymphocyte	NULL
line	NULL
)	NULL
,	NULL
we	NULL
studied	NULL
additional	NULL
B-lymphocyte	NULL
lines	NULL
(	NULL
Daudi	NULL
,	NULL
Plant	NULL
,	NULL
Jiyoye	NULL
,	NULL
CBL-3	NULL
,	NULL
HCLL-7876	NULL
)	NULL
for	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
undetectable	NULL
in	NULL
most	NULL
of	NULL
the	NULL
B-lymphocyte	NULL
lines	NULL
.	NULL

Even	NULL
after	NULL
long	NULL
exposure	NULL
of	NULL
the	NULL
autoradiograms	NULL
(	NULL
10	NULL
days	NULL
)	NULL
,	NULL
only	NULL
Jiyoye	NULL
and	NULL
Plant	NULL
lines	NULL
expressed	NULL
barely	NULL
detectable	NULL
transcripts	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL

K562	NULL
(	NULL
erythroid	NULL
line	NULL
)	NULL
expressed	NULL
and	NULL
Daudi	NULL
(	NULL
B-lymphoid	NULL
line	NULL
)	NULL
did	NULL
not	NULL
express	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
;	NULL
the	NULL
somatic	NULL
hybrid	NULL
formed	NULL
by	NULL
fusion	NULL
of	NULL
the	NULL
two	NULL
lines	NULL
,	NULL
known	NULL
as	NULL
Dutko	NULL
,	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Hybridization	NULL
of	NULL
KIZAKI	NULL
ET	NULL
AL	NULL
Jiyoye	NULL
CBL	NULL
-	NULL
3	NULL
HCLL	NULL
BV173	NULL
S-	NULL
LBI	NULL
ter	NULL
B-	NULL
actin	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
RNA	NULL
in	NULL
human	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
KG-1	NULL
(	NULL
myeloblasts	NULL
)	NULL
,	NULL
HL-60	NULL
(	NULL
promyelocytes	NULL
)	NULL
,	NULL
ML-3	NULL
(	NULL
early	NULL
myelomonoblasts	NULL
}	NULL
,	NULL
U937	NULL
(	NULL
monoblasts	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
monoblasts	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
early	NULL
myeloid/erythroid	NULL
blast	NULL
cells	NULL
)	NULL
,	NULL
Dutko	NULL
(	NULL
hybrid	NULL
cell	NULL
line	NULL
formed	NULL
from	NULL
fusion	NULL
of	NULL
Daudi	NULL
and	NULL
K562	NULL
parental	NULL
lines	NULL
)	NULL
,	NULL
Daudi	NULL
(	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
)	NULL
,	NULL
Plant	NULL
(	NULL
human	NULL
B-lymphoma	NULL
cells	NULL
)	NULL
,	NULL
Jiyoye	NULL
(	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
)	NULL
,	NULL
CBL-3	NULL
(	NULL
EBV-positive	NULL
B-cell	NULL
line	NULL
established	NULL
from	NULL
human	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
with	NULL
MOLT	NULL
4f	NULL
supernatant	NULL
)	NULL
,	NULL
HCLL-7876	NULL
(	NULL
B-cell	NULL
hairy	NULL
cell	NULL
leukemia	NULL
)	NULL
,	NULL
BV173	NULL
(	NULL
B	NULL
lymphocytes	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
lymphoid	NULL
blast	NULL
crisis	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
)	NULL
,	NULL
S-LB1	NULL
(	NULL
T	NULL
lymphoid	NULL
cell	NULL
line	NULL
immortalized	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
technique	NULL
and	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
cDNA	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

A	NULL
single	NULL
band	NULL
was	NULL
detected	NULL
at	NULL
4.6	NULL
kb	NULL
,	NULL
consistent	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

Bottom	NULL
panel	NULL
:	NULL
Hybridization	NULL
of	NULL
the	NULL
same	NULL
RNAs	NULL
with	NULL
P-labeled	NULL
B-actin	NULL
cDNA	NULL
(	NULL
2.1	NULL
kb	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Saturation	NULL
analysis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
binding	NULL
in	NULL
KG-1	NULL
(	NULL
-	NULL
@	NULL
-	NULL
)	NULL
,	NULL
HL-60	NULL
(	NULL
-A-	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
-M-	NULL
)	NULL
,	NULL
BV173	NULL
(	NULL
-O-	NULL
)	NULL
,	NULL
HCLL	NULL
(	NULL
-A-	NULL
)	NULL
,	NULL
CBL-3	NULL
(	NULL
-O-	NULL
)	NULL
,	NULL
and	NULL
S-LB1	NULL
(	NULL
-C-	NULL
)	NULL
cells	NULL
.	NULL

Cell	NULL
homogenates	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
Â°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
overnight	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
bound	NULL
ligand	NULL
was	NULL
separated	NULL
with	NULL
hydroxylapatite	NULL
.	NULL

The	NULL
saturation	NULL
curve	NULL
data	NULL
were	NULL
plotted	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
points	NULL
.	NULL

Receptor	NULL
numbers	NULL
per	NULL
cell	NULL
were	NULL
calculated	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
by	NULL
Scatchard	NULL
analyses	NULL
of	NULL
the	NULL
saturation	NULL
curves	NULL
.	NULL

Receptors/cells	NULL
:	NULL
KG-1	NULL
(	NULL
580	NULL
)	NULL
,	NULL
HL-60	NULL
(	NULL
700	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
2,400	NULL
)	NULL
,	NULL
BV173	NULL
(	NULL
<	NULL
200	NULL
)	NULL
,	NULL
HCLL	NULL
(	NULL
<	NULL
200	NULL
)	NULL
,	NULL
CBL-3	NULL
(	NULL
<	NULL
200	NULL
)	NULL
,	NULL
and	NULL
S-LB1	NULL
(	NULL
12,000	NULL
)	NULL
.	NULL

the	NULL
same	NULL
blot	NULL
with	NULL
a	NULL
P-labeled	NULL
B-actin	NULL
DNA	NULL
probe	NULL
demonstrated	NULL
that	NULL
comparable	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
present	NULL
in	NULL
each	NULL
line	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
showed	NULL
that	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
0OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
receptor	NULL
RNA	NULL
were	NULL
comparable	NULL
in	NULL
wild-type	NULL
HL-60	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
those	NULL
differentiated	NULL
toward	NULL
either	NULL
granulocytes	NULL
or	NULL
macrophages	NULL
(	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
terminally	NULL
differentiated	NULL
granulocyte-	NULL
or	NULL
macrophage-like	NULL
HL-60	NULL
cells	NULL
had	NULL
an	NULL
80	NULL
%	NULL
to	NULL
95	NULL
%	NULL
lower	NULL
level	NULL
of	NULL
'	NULL
H-thymidine	NULL
incorporation	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
HL-60	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
several	NULL
lines	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-DIHYDROXYVITAMIN	NULL
D	NULL
,	NULL
RECEPTOR	NULL
RNA	NULL
was	NULL
determined	NULL
by	NULL
saturation	NULL
analysis	NULL
of	NULL
'	NULL
H-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
binding	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
Northern	NULL
analysis	NULL
,	NULL
BV173	NULL
,	NULL
HCLL	NULL
and	NULL
CBL-3	NULL
,	NULL
which	NULL
are	NULL
all	NULL
B-lymphocyte	NULL
lines	NULL
,	NULL
expressed	NULL
negligible	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
.	NULL

S-LBI1	NULL
(	NULL
T-lymphoid	NULL
line	NULL
)	NULL
cells	NULL
had	NULL
extremely	NULL
high	NULL
amounts	NULL
of	NULL
this	NULL
receptor	NULL
(	NULL
12,000	NULL
per	NULL
cell	NULL
)	NULL
.	NULL

In	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
U937	NULL
cells	NULL
had	NULL
the	NULL
highest	NULL
numbers	NULL
of	NULL
receptors	NULL
per	NULL
cell	NULL
(	NULL
2,400	NULL
per	NULL
cell	NULL
)	NULL
and	NULL
HL-60	NULL
and	NULL
KG-1	NULL
cells	NULL
had	NULL
fewer	NULL
receptors	NULL
(	NULL
700	NULL
and	NULL
580	NULL
per	NULL
cell	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
effects	NULL
on	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

The	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
cellular	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL
``	NULL

''	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
ligand	NULL
regulates	NULL
expression	NULL
of	NULL
its	NULL
own	NULL
receptor	NULL
,	NULL
HL-60	NULL
cells	NULL
1,25	NULL
(	NULL
OH1	NULL
,	NULL
D	NULL
;	NULL
&	NULL
0	NULL
1	NULL
24	NULL
72	NULL
hrs	NULL
.	NULL

4.6kb	NULL
w	NULL
fï¬~	NULL
wit	NULL
us	NULL
VDR	NULL
2.1	NULL
kb	NULL
-	NULL
B-	NULL
actin	NULL
1200-d	NULL
id	NULL
3	NULL
1000	NULL
Â¢	NULL
m4	NULL
[	NULL
>	NULL
w	NULL
800	NULL
8	NULL
$	NULL
w	NULL
V	NULL
m	NULL
Â«	NULL
[	NULL
+3	NULL
?	NULL

400	NULL
4	NULL
2	NULL
2004	NULL
C	NULL
|	NULL
Mr	NULL
re	NULL
~	NULL
,	NULL
l,25	NULL
(	NULL
Ol-l	NULL
)	NULL
2D3	NULL
(	NULL
HRS	NULL
)	NULL
1241	NULL
were	NULL
cultured	NULL
with	NULL
10~	NULL
'	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
various	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
)	NULL
;	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
and	NULL
receptor	NULL
binding	NULL
assays	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

DNA	NULL
synthesis	NULL
was	NULL
analyzed	NULL
by	NULL
*	NULL
'	NULL
H-thymidine	NULL
incorporation	NULL
(	NULL
Fig	NULL
2C	NULL
)	NULL
.	NULL

DNA	NULL
synthesis	NULL
began	NULL
to	NULL
decrease	NULL
at	NULL
24-hour	NULL
exposure	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
;	NULL
at	NULL
72	NULL
hours	NULL
,	NULL
DNA	NULL
synthesis	NULL
was	NULL
about	NULL
one	NULL
sixth	NULL
of	NULL
wild-type	NULL
HL-60	NULL
cells	NULL
.	NULL

Levels	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
were	NULL
not	NULL
modulated	NULL
by	NULL
either	NULL
short	NULL
(	NULL
1	NULL
hour	NULL
)	NULL
or	NULL
long	NULL
(	NULL
72	NULL
hour	NULL
)	NULL
exposure	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
ligand	NULL
,	NULL
however	NULL
,	NULL
indicating	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
,	NULL
and	NULL
expression	NULL
appeared	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
cell	NULL
division	NULL
.	NULL

To	NULL
analyze	NULL
modulation	NULL
of	NULL
this	NULL
receptor	NULL
after	NULL
the	NULL
cells	NULL
Â©	NULL
5000	NULL
4000	NULL
3000	NULL
2000	NULL
1000	NULL
PH	NULL
]	NULL
-THYMIDINE	NULL
INCORPORATION	NULL
(	NULL
CPM/IOSCELLS	NULL
)	NULL
0	NULL
1	NULL
24	NULL
72	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
2	NULL
%	NULL
(	NULL
hrs	NULL
)	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
ligand	NULL
on	NULL
levels	NULL
of	NULL
RNA	NULL
and	NULL
protein	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
and	NULL
Â°H-thymidine	NULL
incorporation	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
10	NULL
~	NULL
'	NULL
mol/L	NULL
for	NULL
various	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
)	NULL
.	NULL

Panel	NULL
A	NULL
:	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNAs	NULL
was	NULL
performed	NULL
by	NULL
blotting	NULL
poly-A*	NULL
RNA	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

The	NULL
4.6-	NULL
and	NULL
2.1-kb	NULL
hybridizing	NULL
bands	NULL
are	NULL
consistent	NULL
with	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
and	NULL
B-actin	NULL
,	NULL
respectively	NULL
.	NULL

Panel	NULL
B	NULL
:	NULL
Occupied	NULL
(	NULL
-	NULL
@	NULL
-	NULL
)	NULL
,	NULL
unoccupied	NULL
(	NULL
-A-	NULL
)	NULL
,	NULL
and	NULL
total	NULL
(	NULL
-O-	NULL
)	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
treatment	NULL
for	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
with	NULL
10~	NULL
mol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
.	NULL

Receptor	NULL
quantitation	NULL
is	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

Data	NULL
points	NULL
are	NULL
the	NULL
means	NULL
+	NULL
SE	NULL
,	NULL
each	NULL
plotted	NULL
in	NULL
triplicate	NULL
.	NULL

Panel	NULL
C	NULL
:	NULL
Time	NULL
course	NULL
of	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
(	NULL
10~	NULL
mol/L	NULL
)	NULL
on	NULL
DNA	NULL
synthesis	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
absolute	NULL
Â°H-thymidine	NULL
incorporation	NULL
(	NULL
per	NULL
10Â°	NULL
cells	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
cultures	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
same	NULL
cell	NULL
cultures	NULL
were	NULL
used	NULL
for	NULL
analysis	NULL
of	NULL
RNA	NULL
,	NULL
protein	NULL
,	NULL
and	NULL
Â°H-thymidine	NULL
incorporation	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1242	NULL
were	NULL
cultured	NULL
with	NULL
the	NULL
ligand	NULL
,	NULL
we	NULL
examined	NULL
occupied	NULL
and	NULL
unoccupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptors	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
different	NULL
lengths	NULL
of	NULL
exposure	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
;	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
occupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptors	NULL
during	NULL
the	NULL
72-hour	NULL
culture	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
occupied	NULL
receptors	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
unoccupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
.	NULL

The	NULL
total	NULL
number	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
(	NULL
occupied	NULL
plus	NULL
unoccupied	NULL
)	NULL
was	NULL
down	NULL
regulated	NULL
about	NULL
50	NULL
%	NULL
at	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
began	NULL
to	NULL
return	NULL
toward	NULL
basal	NULL
levels	NULL
at	NULL
72	NULL
hours	NULL
.	NULL

Nondividing	NULL
macrophages	NULL
express	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
RNA	NULL
,	NULL
and	NULL
RNA	NULL
levels	NULL
do	NULL
not	NULL
change	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
TNF-a	NULL
or	NULL
LT.	NULL
-	NULL
Human	NULL
macrophages	NULL
are	NULL
nondividing	NULL
cells	NULL
.	NULL

Both	NULL
TNF-a	NULL
and	NULL
LT	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
macrophages	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
macrophages	NULL
constitutively	NULL
expressed	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
exposure	NULL
to	NULL
either	NULL
TNF-a	NULL
(	NULL
10Â°	NULL
U/mL	NULL
)	NULL
or	NULL
LT	NULL
(	NULL
10Â°	NULL
U/mL	NULL
)	NULL
for	NULL
8	NULL
hours	NULL
did	NULL
not	NULL
change	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

These	NULL
cytokines	NULL
did	NULL
stimulate	NULL
accumulation	NULL
of	NULL
M-CSF	NULL
RNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Macrophages	NULL
had	NULL
very	NULL
little	NULL
Â°H-thymidine	NULL
incorporation	NULL
as	NULL
compared	NULL
with	NULL
actively	NULL
dividing	NULL
cells	NULL
(	NULL
HL-60	NULL
)	NULL
and	NULL
levels	NULL
of	NULL
Â°H-thymidine	NULL
incorporation	NULL
did	NULL
not	NULL
change	NULL
during	NULL
exposure	NULL
to	NULL
either	NULL
TNF-	NULL
Â«	NULL
or	NULL
LT	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
parallels	NULL
cellular	NULL
proliferation	NULL
in	NULL
lymphocytes	NULL
.	NULL

-	NULL
Most	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
are	NULL
in	NULL
the	NULL
resting	NULL
stage	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
.	NULL

Many	NULL
can	NULL
be	NULL
stimulated	NULL
to	NULL
proliferate	NULL
after	NULL
exposure	NULL
to	NULL
a	NULL
mito-gen.	NULL
Levels	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
synthesis	NULL
of	NULL
DNA	NULL
as	NULL
measured	NULL
by	NULL
'	NULL
H-thymidine	NULL
incorporation	NULL
were	NULL
examined	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
stimulated	NULL
by	NULL
0.5	NULL
%	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
for	NULL
different	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
)	NULL
.	NULL
'	NULL

H-Thymidine	NULL
incorporation	NULL
increased	NULL
in	NULL
a	NULL
time-dependent	NULL
fashion	NULL
;	NULL
after	NULL
exposure	NULL
to	NULL
PHA	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
it	NULL
was	NULL
10.5-fold	NULL
above	NULL
baseline	NULL
;	NULL
at	NULL
48	NULL
and	NULL
72	NULL
hours	NULL
,	NULL
it	NULL
was	NULL
36.5-	NULL
and	NULL
50-fold	NULL
greater	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
unstimulated	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Resting	NULL
lymphocytes	NULL
expressed	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

Levels	NULL
increased	NULL
fivefold	NULL
after	NULL
24	NULL
hours	NULL
and	NULL
greater	NULL
than	NULL
sixfold	NULL
after	NULL
48	NULL
and	NULL
72	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
PHA	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

Half-life	NULL
of	NULL
steady-state	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
is	NULL
short	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
stability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
RNA	NULL
,	NULL
using	NULL
S-LB1	NULL
T	NULL
lymphocytes	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
pg/mL	NULL
)	NULL
for	NULL
different	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
8	NULL
hours	NULL
)	NULL
.	NULL

RNA	NULL
samples	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

Figure	NULL
5B	NULL
summarizes	NULL
the	NULL
densitometry	NULL
readings	NULL
of	NULL
the	NULL
autoradiogram	NULL
of	NULL
the	NULL
Northern	NULL
blot	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
.	NULL

The	NULL
half-life	NULL
(	NULL
t	NULL
)	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
approximately	NULL
1	NULL
hour	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
increases	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
receptor	NULL
RNA	NULL
.	NULL

-	NULL
Certain	NULL
RNA	NULL
species	NULL
with	NULL
short	NULL
t	NULL
%	NULL
are	NULL
stabilized	NULL
by	NULL
CHX	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibi-tor	NULL
.	NULL
``	NULL

We	NULL
analyzed	NULL
the	NULL
role	NULL
of	NULL
protein	NULL
synthesis	NULL
in	NULL
regulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
accumulation	NULL
.	NULL

S-LB1	NULL
(	NULL
T	NULL
lymphocytes	NULL
)	NULL
and	NULL
Lu-CSF-1	NULL
(	NULL
lung	NULL
adenocarcinoma	NULL
cells	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
CHX	NULL
(	NULL
20	NULL
ug/mL	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

CHX	NULL
increased	NULL
accumulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
KIZAKI	NULL
ET	NULL
AL	NULL
S-LB1	NULL
cells	NULL
by	NULL
threefold	NULL
and	NULL
in	NULL
Lu-CSF-1	NULL
cells	NULL
by	NULL
20-fold	NULL
as	NULL
compared	NULL
with	NULL
unstimulated	NULL
,	NULL
matched	NULL
control	NULL
samples	NULL
.	NULL

DISCUSSION	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
is	NULL
the	NULL
physiologically	NULL
important	NULL
secosteroid	NULL
that	NULL
mediates	NULL
calcium	NULL
resorption	NULL
of	NULL
bone	NULL
and	NULL
intestinal	NULL
calcium	NULL
absorption	NULL
.	NULL
``	NULL

It	NULL
also	NULL
has	NULL
effects	NULL
on	NULL
hematopoiesis	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL
'	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
induces	NULL
terminal	NULL
differentiation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
and	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
as	NULL
normal	NULL
committed	NULL
myeloid	NULL
stem	NULL
cells	NULL
.	NULL
``	NULL

It	NULL
decreases	NULL
synthesis	NULL
of	NULL
immunoglobulins	NULL
by	NULL
B	NULL
lymphocytes	NULL
``	NULL
and	NULL
decreases	NULL
synthesis	NULL
of	NULL
lymphokines	NULL
by	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

These	NULL
effects	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
are	NULL
probably	NULL
mediated	NULL
directly	NULL
or	NULL
indirectly	NULL
by	NULL
initial	NULL
ligand	NULL
binding	NULL
to	NULL
intracellular	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL
``	NULL

The	NULL
putative	NULL
DNA-binding	NULL
region	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
has	NULL
strong	NULL
homolo-gies	NULL
to	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
all	NULL
the	NULL
other	NULL
steroid	NULL
hormone	NULL
receptors	NULL
and	NULL
with	NULL
the	NULL
v-erbA	NULL
oncogene	NULL
.	NULL
``	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
belongs	NULL
to	NULL
the	NULL
same	NULL
supergene	NULL
family	NULL
with	NULL
the	NULL
other	NULL
classic	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

The	NULL
similarity	NULL
of	NULL
structure	NULL
of	NULL
the	NULL
steroid	NULL
family	NULL
of	NULL
receptor	NULL
genes	NULL
suggests	NULL
a	NULL
commonality	NULL
in	NULL
their	NULL
mechanism	NULL
of	NULL
function	NULL
.	NULL

Except	NULL
for	NULL
B-lymphocyte	NULL
lines	NULL
,	NULL
all	NULL
of	NULL
the	NULL
actively	NULL
proliferating	NULL
hematopoietic	NULL
cells	NULL
we	NULL
examined	NULL
expressed	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
.	NULL

The	NULL
4.6-kb	NULL
size	NULL
of	NULL
a	NULL
single	NULL
RNA	NULL
transcript	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
a	NULL
human	NULL
breast	NULL
cancer	NULL
cell	NULL
line	NULL
and	NULL
a	NULL
human	NULL
intestinal	NULL
cell	NULL
line	NULL
.	NULL
``	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
RNA	NULL
were	NULL
not	NULL
modulated	NULL
by	NULL
exposure	NULL
to	NULL
high	NULL
concentrations	NULL
of	NULL
the	NULL
ligand	NULL
for	NULL
24	NULL
to	NULL
72	NULL
hours	NULL
.	NULL

Similarly	NULL
,	NULL
glucocorticoid	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
levels	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
lymphocytes	NULL
.	NULL
``	NULL

Our	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor-binding	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
number	NULL
of	NULL
occupied	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
was	NULL
increased	NULL
and	NULL
the	NULL
number	NULL
of	NULL
unoccupied	NULL
receptors	NULL
was	NULL
decreased	NULL
by	NULL
culture	NULL
with	NULL
the	NULL
ligand	NULL
.	NULL

The	NULL
total	NULL
number	NULL
of	NULL
receptors	NULL
decreased	NULL
about	NULL
50	NULL
%	NULL
at	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
began	NULL
to	NULL
return	NULL
toward	NULL
baseline	NULL
at	NULL
72	NULL
hours	NULL
of	NULL
culture	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

These	NULL
RNA	NULL
and	NULL
receptor	NULL
data	NULL
suggest	NULL
that	NULL
partial	NULL
regulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
levels	NULL
occur	NULL
posttranscription-ally	NULL
without	NULL
alterations	NULL
in	NULL
cellular	NULL
levels	NULL
of	NULL
transcripts	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
vitamin	NULL
D	NULL
,	NULL
metabolites	NULL
upregulated	NULL
the	NULL
number	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
a	NULL
porcine	NULL
kidney	NULL
cell	NULL
line	NULL
(	NULL
LLC-PK1	NULL
)	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
investigators	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
showed	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
increased	NULL
at	NULL
12	NULL
hours	NULL
and	NULL
returned	NULL
toward	NULL
baseline	NULL
at	NULL
48	NULL
and	NULL
72	NULL
hours	NULL
when	NULL
HL-60	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL
``	NULL

This	NULL
discrepancy	NULL
between	NULL
our	NULL
data	NULL
and	NULL
theirs	NULL
is	NULL
unclear	NULL
.	NULL

We	NULL
used	NULL
50-fold	NULL
more	NULL
ligand	NULL
(	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
;	NULL
this	NULL
concentration	NULL
induces	NULL
maximum	NULL
differentiation	NULL
without	NULL
cytotoxicity	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
measured	NULL
receptor	NULL
numbers	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
ligand	NULL
as	NULL
compared	NULL
with	NULL
immunoprecipitation	NULL
of	NULL
the	NULL
receptors	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
technique	NULL
may	NULL
explain	NULL
differences	NULL
in	NULL
results	NULL
at	NULL
24	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
ligand	NULL
.	NULL

Our	NULL
later	NULL
time	NULL
points	NULL
(	NULL
72	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
ligand	NULL
)	NULL
are	NULL
not	NULL
divergent	NULL
.	NULL
``	NULL

Expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
lympho-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-DIHYDROXYVITAMIN	NULL
D	NULL
,	NULL
RECEPTOR	NULL
RNA	NULL
Fig	NULL
3	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
Receptor	NULL
RNA	NULL
in	NULL
normal	NULL
human	NULL
macrophages	NULL
.	NULL

Panel	NULL
A	NULL
:	NULL
Macrophages	NULL
either	NULL
alone	NULL
or	NULL
after	NULL
8-hours	NULL
exposure	NULL
to	NULL
either	NULL
TNF-	NULL
Â«	NULL
10Â°	NULL
U/mL	NULL
or	NULL
LT	NULL
,	NULL
10Â°	NULL
U/mL	NULL
were	NULL
analyzed	NULL
sequentially	NULL
by	NULL
Northern	NULL
blot	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
(	NULL
4.6-kb	NULL
bands	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
B-actin	NULL
transcripts	NULL
(	NULL
2.1-kb	NULL
bands	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

Panel	NULL
B	NULL
:	NULL
DNA	NULL
synthesis	NULL
was	NULL
measured	NULL
by	NULL
*H-thymidine	NULL
incorporation	NULL
(	NULL
per	NULL
10Â°	NULL
cells	NULL
)	NULL
in	NULL
untreated	NULL
TNF-	NULL
Â«	NULL
10Â°	NULL
U/mL	NULL
and	NULL
LT	NULL
10Â°	NULL
U/mL	NULL
treated	NULL
macrophages	NULL
shown	NULL
in	NULL
Panel	NULL
A.	NULL
Wild-type	NULL
HL-60	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
for	NULL
*H-thymidine	NULL
incorporation	NULL
(	NULL
per	NULL
10Â°	NULL
cells	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
cultures	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

cytes	NULL
(	NULL
presumably	NULL
T	NULL
lymphocytes	NULL
)	NULL
correlated	NULL
with	NULL
their	NULL
proliferative	NULL
status	NULL
.	NULL

No	NULL
detectable	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
was	NULL
found	NULL
in	NULL
nonproliferating	NULL
lymphocytes	NULL
harvested	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
,	NULL
but	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
transcripts	NULL
became	NULL
prominent	NULL
after	NULL
24-hour	NULL
exposure	NULL
to	NULL
PHA	NULL
.	NULL

This	NULL
paralleled	NULL
initiation	NULL
of	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
1243	NULL
VDR	NULL
B-	NULL
actin	NULL
5000	NULL
7	NULL
;	NULL
1d	NULL
1d	NULL
E	NULL
m0	NULL
9	NULL
4000	NULL
{	NULL
4	NULL
B	NULL
B4	NULL
J	NULL
Z	NULL
G	NULL
E	NULL
-	NULL
3000	NULL
p	NULL
0	NULL
Ba	NULL
~	NULL
9	NULL
&	NULL
2000	NULL
4	NULL
a	NULL
Â«	NULL
a	NULL
E	NULL
1000	NULL
~	NULL
0-CONTROL	NULL
TNF-	NULL
LT	NULL
HL-60	NULL
e	NULL
MACROPHAGE	NULL
previous	NULL
studies	NULL
using	NULL
radioactive	NULL
ligand	NULL
,	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptor	NULL
was	NULL
present	NULL
in	NULL
proliferating	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
studies	NULL
suggest	NULL
that	NULL
stimulation	NULL
of	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
during	NULL
initiation	NULL
of	NULL
proliferation	NULL
of	NULL
lymphocytes	NULL
is	NULL
at	NULL
least	NULL
in	NULL
part	NULL
modulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
RNA	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1244	NULL
KIZAKI	NULL
ET	NULL
AL	NULL
PHA	NULL
@	NULL
O0	NULL
4	NULL
24	NULL
48	NULL
72	NULL
hrs	NULL
.	NULL

-	NULL
p	NULL
ope	NULL
:	NULL
g	NULL
``	NULL
Â»	NULL
ï¬	NULL
4.6	NULL
kb	NULL
Fold	NULL
Stimulation	NULL
:	NULL
2.1	NULL
kb	NULL
10000	NULL
1	NULL
a	NULL
Â«	NULL
3	NULL
8	NULL
8000	NULL
~	NULL
RC	NULL
=	NULL
=	NULL
Pr	NULL
2	NULL
Z	NULL
Â©	NULL
-	NULL
6000	NULL
<	NULL
E	NULL
<	NULL
F4	NULL
&	NULL
fix	NULL
5	NULL
O	NULL
-	NULL
4000	NULL
<	NULL
[	NULL
3	NULL
[	NULL
=	NULL
]	NULL
po	NULL
E	NULL
2000	NULL
+	NULL
E	NULL
4	NULL
0	NULL
.	NULL

0	NULL
4	NULL
24	NULL
48	NULL
72	NULL
PHA	NULL
(	NULL
hrs	NULL
)	NULL
Investigations	NULL
have	NULL
shown	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
has	NULL
inhibi-tory	NULL
effects	NULL
on	NULL
synthesis	NULL
of	NULL
immunoglobulins	NULL
by	NULL
B	NULL
lympho-cytes	NULL
;	NULL
whether	NULL
this	NULL
represents	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
on	NULL
B	NULL
lymphocytes	NULL
``	NULL
or	NULL
an	NULL
indirect	NULL
effect	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
by	NULL
inhibiting	NULL
T-helper	NULL
cell	NULL
activity	NULL
is	NULL
controversial	NULL
.	NULL
``	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
B	NULL
lymphocytes	NULL
express	NULL
either	NULL
low	NULL
or	NULL
negligible	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
and	NULL
protein	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
inhibits	NULL
production	NULL
of	NULL
interleu-kin-2	NULL
and	NULL
other	NULL
lymphokines	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
``	NULL
;	NULL
1.0	NULL
1.0	NULL
5.2	NULL
6.3	NULL
6.4	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
resting	NULL
and	NULL
proliferating	NULL
lymphocytes	NULL
.	NULL

Panel	NULL
A	NULL
:	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
Receptor	NULL
RNA	NULL
levels	NULL
in	NULL
normal	NULL
human	NULL
lymphocytes	NULL
after	NULL
treatment	NULL
with	NULL
0.5	NULL
%	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
for	NULL
different	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
)	NULL
.	NULL

Analysis	NULL
was	NULL
performed	NULL
by	NULL
blotting	NULL
total	NULL
RNA	NULL
from	NULL
lymphocytes	NULL
and	NULL
sequentially	NULL
hybridizing	NULL
with	NULL
``	NULL
P-labeled	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
cDNA	NULL
(	NULL
4.6-kb	NULL
bands	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
and	NULL
B-actin	NULL
cDNA	NULL
(	NULL
2.1-kb	NULL
bands	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

Fold	NULL
stimulation	NULL
of	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
level	NULL
in	NULL
untreated	NULL
cells	NULL
was	NULL
equalized	NULL
for	NULL
levels	NULL
of	NULL
G-actin	NULL
(	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
)	NULL
.	NULL

Panel	NULL
B	NULL
:	NULL
Â°H-Thymidine	NULL
incorporation	NULL
by	NULL
normal	NULL
human	NULL
lymphocytes	NULL
after	NULL
treatment	NULL
with	NULL
0.5	NULL
%	NULL
PHA	NULL
for	NULL
0	NULL
to	NULL
72	NULL
hours	NULL
.	NULL

Studies	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
absolute	NULL
*H-thymidine	NULL
incorporation	NULL
(	NULL
per	NULL
10Â°	NULL
cells	NULL
)	NULL
.	NULL

Same	NULL
cell	NULL
cultures	NULL
were	NULL
used	NULL
for	NULL
analysis	NULL
of	NULL
both	NULL
RNA	NULL
and	NULL
Â°H-thymidine	NULL
incorporation	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
cultures	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

this	NULL
probably	NULL
results	NULL
in	NULL
suppression	NULL
of	NULL
immunoglobulin	NULL
synthesis	NULL
by	NULL
B	NULL
lymphocytes	NULL
.	NULL

Additional	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
confirm	NULL
that	NULL
purified	NULL
B	NULL
lymphocytes	NULL
from	NULL
normal	NULL
individuals	NULL
do	NULL
not	NULL
express	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

Of	NULL
further	NULL
interest	NULL
,	NULL
the	NULL
fusion	NULL
of	NULL
Daudi	NULL
(	NULL
a	NULL
B-lymphoid	NULL
line	NULL
that	NULL
is	NULL
a	NULL
nonexpressor	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
)	NULL
and	NULL
K562	NULL
(	NULL
an	NULL
erythroid	NULL
line	NULL
that	NULL
is	NULL
an	NULL
expressor	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
somatic	NULL
hybrid	NULL
Dutko	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
nonexpression	NULL
of	NULL
the	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-DIHYDROXYVITAMIN	NULL
D	NULL
,	NULL
RECEPTOR	NULL
RNA	NULL
1245	NULL
Actinomycin	NULL
D	NULL
0	NULL
q	NULL
&	NULL
4	NULL
204	NULL
8	NULL
drs	NULL
.	NULL

Fig	NULL
5	NULL
.	NULL

-	NULL
Determination	NULL
of	NULL
t/	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Panel	NULL
A	NULL
:	NULL
T	NULL
lymphocytes	NULL
(	NULL
S-LB1	NULL
)	NULL
were	NULL
exposed	NULL
for	NULL
various	NULL
durations	NULL
(	NULL
0	NULL
to	NULL
8	NULL
hours	NULL
)	NULL
to	NULL
actinomycin	NULL
D	NULL
(	NULL
5	NULL
g/mL	NULL
)	NULL
,	NULL
and	NULL
cytoplasmic	NULL
RNA	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
sequentially	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
cDNA	NULL
(	NULL
4.6-kb	NULL
bands	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
B-actin	NULL
cDNA	NULL
(	NULL
2.1-kb	NULL
bands	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

The	NULL
t	NULL
?	NULL

of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
receptor	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
decay	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
levels	NULL
.	NULL

Panel	NULL
B	NULL
:	NULL
Diagram	NULL
of	NULL
autoradiogram	NULL
shown	NULL
in	NULL
Fig	NULL
6A	NULL
as	NULL
quantitated	NULL
by	NULL
densitometry	NULL
using	NULL
the	NULL
control	NULL
sample	NULL
(	NULL
no	NULL
actinomycin	NULL
D	NULL
)	NULL
as	NULL
100	NULL
%	NULL
accumulation	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
is	NULL
a	NULL
dominant	NULL
feature	NULL
.	NULL

Perhaps	NULL
B	NULL
lymphocytes	NULL
express	NULL
a	NULL
trans-acting	NULL
dominant	NULL
repressor	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
lymphocytes	NULL
,	NULL
nondividing	NULL
,	NULL
terminally	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
and	NULL
normal	NULL
macrophages	NULL
expressed	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
either	NULL
RA	NULL
or	NULL
DMSO	NULL
and	NULL
differentiated	NULL
to	NULL
granulocytes	NULL
or	NULL
cultured	NULL
with	NULL
either	NULL
TPA	NULL
or	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
differentiated	NULL
to	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
either	NULL
case	NULL
,	NULL
the	NULL
cells	NULL
lost	NULL
proliferative	NULL
capacity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
human	NULL
macrophages	NULL
were	NULL
not	NULL
dividing	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
their	NULL
low	NULL
Â°*H-thymidine	NULL
incorporation	NULL
in	NULL
our	NULL
experiments	NULL
;	NULL
never-theless	NULL
,	NULL
these	NULL
cells	NULL
expressed	NULL
abundant	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
transcripts	NULL
.	NULL

Further	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
activated	NULL
monocytes	NULL
express	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL
``	NULL

We	NULL
previ-	NULL
just	NULL
&	NULL
&	NULL
A	NULL
RELATIVE	NULL
INTENSITY	NULL
(	NULL
%	NULL
)	NULL
w	NULL
&	NULL
4.0	NULL
-	NULL
6.0	NULL
-	NULL
8.0	NULL
TIME	NULL
(	NULL
brs	NULL
)	NULL
ously	NULL
showed	NULL
that	NULL
macrophages	NULL
activated	NULL
by	NULL
y-interferon	NULL
(	NULL
y-IFN	NULL
)	NULL
can	NULL
synthesize	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
their	NULL
synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
can	NULL
be	NULL
controlled	NULL
by	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
in	NULL
the	NULL
culture	NULL
media	NULL
'	NULL
``	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
can	NULL
control	NULL
levels	NULL
of	NULL
production	NULL
of	NULL
y-IFN	NULL
and	NULL
other	NULL
cytokines	NULL
produced	NULL
by	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

From	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
macrophages	NULL
and	NULL
activated	NULL
T	NULL
lymphocytes	NULL
might	NULL
interact	NULL
in	NULL
a	NULL
paracrine	NULL
fashion	NULL
using	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
y-IFN	NULL
as	NULL
signals	NULL
.	NULL
``	NULL

Our	NULL
present	NULL
data	NULL
on	NULL
RNA	NULL
expression	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptors	NULL
suggest	NULL
that	NULL
the	NULL
proposed	NULL
interaction	NULL
is	NULL
possible	NULL
.	NULL

The	NULL
t	NULL
%	NULL
of	NULL
RNA	NULL
coding	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
receptors	NULL
in	NULL
T	NULL
lymphocytes	NULL
was	NULL
1	NULL
hour	NULL
.	NULL

A	NULL
similar	NULL
instability	NULL
was	NULL
noted	NULL
for	NULL
RNA	NULL
coding	NULL
for	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
(	NULL
120	NULL
minutes	NULL
in	NULL
lymphocytes	NULL
)	NULL
``	NULL
and	NULL
RA	NULL
receptors	NULL
(	NULL
40	NULL
minutes	NULL
in	NULL
T	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1246	NULL
KIZAKI	NULL
ET	NULL
AL	NULL
SLB-1	NULL
-	NULL
Lu-CSF-4	NULL
GO	NULL
a-	NULL
}	NULL
@	NULL
a	NULL
@	NULL
oue	NULL
Â»	NULL
Â«	NULL
fpm	NULL
O	NULL
O	NULL
2	NULL
â¬	NULL
t	NULL
Pas	NULL
Sam	NULL
``	NULL
s	NULL
-	NULL
p	NULL
Fig	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
inhibition	NULL
of	NULL
e	NULL
I	NULL
e	NULL
&	NULL
.	NULL

protein	NULL
synthesis	NULL
on	NULL
accumula-D	NULL
o	NULL
D	NULL
o	NULL
tion	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
.	NULL

``	NULL
S-LB1	NULL
T	NULL
lymphocytes	NULL
and	NULL
Lu-al	NULL
CSF-1	NULL
cells	NULL
(	NULL
lung	NULL
adenocarcinoma	NULL
:	NULL
cells	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
CHX	NULL
{	NULL
.	NULL

aH	NULL
(	NULL
20	NULL
g/mL	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Cytoplas-4	NULL
6	NULL
kb	NULL
cae	NULL
``	NULL
VDR	NULL
mic	NULL
RNA	NULL
from	NULL
untreated	NULL
and	NULL
*	NULL
CHX-treated	NULL
S-LB1	NULL
cells	NULL
and	NULL
Lu-CSF-1	NULL
cells	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
by	NULL
RNA	NULL
blotting	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
.	NULL

Blots	NULL
were	NULL
se-0/0	NULL
Accumulation	NULL
100	NULL
297100	NULL
1970	NULL
quentially	NULL
hybridized	NULL
with	NULL
``	NULL
P-	NULL
2.1	NULL
kb	NULL
lymphocytes	NULL
)	NULL
.	NULL
``	NULL

The	NULL
instability	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
RNA	NULL
allows	NULL
for	NULL
rapid	NULL
modulation	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
transcripts	NULL
.	NULL

Inhibition	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
by	NULL
cycloheximide	NULL
increased	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
threefold	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
S-LB1	NULL
)	NULL
and	NULL
20-fold	NULL
in	NULL
Lu-CSF-1	NULL
cells	NULL
.	NULL

Other	NULL
genes	NULL
with	NULL
transiently	NULL
expressed	NULL
transcripts	NULL
such	NULL
as	NULL
MYC	NULL
and	NULL
FOS	NULL
also	NULL
are	NULL
superinduced	NULL
by	NULL
CHX	NULL
,	NULL
**	NULL
suggest	NULL
labeled	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
cDNA	NULL
(	NULL
4.6-kb	NULL
bands	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
and	NULL
with	NULL
a	NULL
B-actin	NULL
DNA	NULL
probe	NULL
(	NULL
2.1-kb	NULL
bands	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

Intensity	NULL
of	NULL
hybridization	NULL
was	NULL
determined	NULL
by	NULL
densitometry	NULL
.	NULL

For	NULL
percentage	NULL
of	NULL
accumulation	NULL
,	NULL
each	NULL
untreated	NULL
cell	NULL
was	NULL
compared	NULL
with	NULL
cells	NULL
treated	NULL
with	NULL
CHX	NULL
.	NULL

B-	NULL
actin	NULL
ing	NULL
that	NULL
a	NULL
negatively	NULL
regulating	NULL
trans-acting	NULL
protein	NULL
may	NULL
be	NULL
modulating	NULL
levels	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
receptor	NULL
transcripts	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Elisa	NULL
Weiss	NULL
,	NULL
Elaine	NULL
Epstein	NULL
,	NULL
and	NULL
Margery	NULL
Goldberg	NULL
for	NULL
excellent	NULL
secretarial	NULL
help	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Reichel	NULL
H	NULL
,	NULL
Koeffier	NULL
HP	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
The	NULL
role	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
endocrine	NULL
system	NULL
in	NULL
health	NULL
and	NULL
disease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
320:980	NULL
,	NULL
1989	NULL
2	NULL
.	NULL

Henry	NULL
HL	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
Vitamin	NULL
D	NULL
:	NULL
Metabolism	NULL
and	NULL
biological	NULL
actions	NULL
.	NULL

Annu	NULL
Rev	NULL
Nutr	NULL
4:493	NULL
,	NULL
1984	NULL
3	NULL
.	NULL

Bell	NULL
NH	NULL
:	NULL
Vitamin	NULL
D-Endocrine	NULL
system	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
76:1	NULL
,	NULL
1985	NULL
4	NULL
.	NULL

Bromonage	NULL
R	NULL
,	NULL
DeLuca	NULL
HF	NULL
:	NULL
Evidence	NULL
that	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
is	NULL
the	NULL
physiological	NULL
active	NULL
metabolite	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
.	NULL

Endocr	NULL
Rev	NULL
6:491	NULL
,	NULL
1985	NULL
5	NULL
.	NULL

Monolagas	NULL
SC	NULL
,	NULL
Deftos	NULL
LJ	NULL
:	NULL
The	NULL
vitamin	NULL
D	NULL
endocrine	NULL
system	NULL
and	NULL
the	NULL
hematolymphopoietic	NULL
tissue	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
100:144	NULL
,	NULL
1986	NULL
6	NULL
.	NULL

Abe	NULL
E	NULL
,	NULL
Miyaura	NULL
C	NULL
,	NULL
Sakagami	NULL
H	NULL
,	NULL
Takeda	NULL
M	NULL
,	NULL
Konno	NULL
K	NULL
,	NULL
Yamazaki	NULL
T	NULL
,	NULL
Yoshiki	NULL
S	NULL
,	NULL
Suda	NULL
T	NULL
:	NULL
Differentiation	NULL
of	NULL
mouse	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
induced	NULL
by	NULL
1	NULL
alpha	NULL
,	NULL
25	NULL
dihydroxyvitamin	NULL
D	NULL
,	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
78:4990	NULL
,	NULL
1981	NULL
7	NULL
.	NULL

Bar-Shevit	NULL
Z	NULL
,	NULL
Teitelbaum	NULL
SL	NULL
,	NULL
Reitsma	NULL
P	NULL
,	NULL
Hall	NULL
A	NULL
,	NULL
Pegg	NULL
LE	NULL
,	NULL
Trial	NULL
J	NULL
,	NULL
Kahn	NULL
A	NULL
:	NULL
Induction	NULL
of	NULL
monocyte	NULL
differentiation	NULL
and	NULL
bone	NULL
resorption	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
80:5907	NULL
,	NULL
1983	NULL
8	NULL
.	NULL

Mangelsdorf	NULL
DJ	NULL
,	NULL
Koefflet	NULL
HP	NULL
,	NULL
Donaldson	NULL
CA	NULL
,	NULL
Pike	NULL
JW	NULL
,	NULL
Haussler	NULL
MR	NULL
:	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
-induced	NULL
differentiation	NULL
in	NULL
a	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
:	NULL
Receptor-mediated	NULL
maturation	NULL
to	NULL
macrophage	NULL
like	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
98:391	NULL
,	NULL
1984	NULL
9	NULL
.	NULL

Tanaka	NULL
H	NULL
,	NULL
Abe	NULL
E	NULL
,	NULL
Miyaura	NULL
C	NULL
,	NULL
Kuribayashi	NULL
T	NULL
,	NULL
Konno	NULL
K	NULL
,	NULL
Nishi	NULL
Y	NULL
,	NULL
Suda	NULL
T	NULL
:	NULL
1	NULL
Alpha,25-dihydroxycholecalciferol	NULL
and	NULL
a	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
.	NULL

Biochem	NULL
J	NULL
204:713	NULL
,	NULL
1982	NULL
10	NULL
.	NULL

Haussler	NULL
MR	NULL
,	NULL
McCain	NULL
TA	NULL
:	NULL
Basic	NULL
and	NULL
clinical	NULL
concepts	NULL
related	NULL
to	NULL
vitamin	NULL
D	NULL
metabolism	NULL
and	NULL
action	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
297:974	NULL
,	NULL
1977	NULL
11	NULL
.	NULL

Haussler	NULL
MR	NULL
:	NULL
Vitamin	NULL
D	NULL
receptors	NULL
:	NULL
Nature	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
Rev	NULL
Nutr	NULL
6:527	NULL
,	NULL
1986	NULL
12	NULL
.	NULL

McDonnel	NULL
DP	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
,	NULL
Pike	NULL
JW	NULL
,	NULL
Haussler	NULL
MR	NULL
,	NULL
O'Malley	NULL
BW	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
complementary	NULL
DNA	NULL
encoding	NULL
the	NULL
avian	NULL
receptor	NULL
for	NULL
vitamin	NULL
D.	NULL
Science	NULL
235:1214	NULL
,	NULL
1987	NULL
13	NULL
.	NULL

Burmester	NULL
JK	NULL
,	NULL
Wiese	NULL
RJ	NULL
,	NULL
Maeda	NULL
N	NULL
,	NULL
DeLuca	NULL
HF	NULL
:	NULL
Structure	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
rat	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
receptor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:9499	NULL
,	NULL
1988	NULL
14	NULL
.	NULL

Baker	NULL
AR	NULL
,	NULL
McDonnell	NULL
DP	NULL
,	NULL
Huges	NULL
M	NULL
,	NULL
Crisp	NULL
TM	NULL
,	NULL
Mangelsdorf	NULL
DJ	NULL
,	NULL
Haussler	NULL
MR	NULL
,	NULL
Pike	NULL
JW	NULL
,	NULL
Shine	NULL
J	NULL
,	NULL
O'Malley	NULL
BW	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
human	NULL
vitamin	NULL
D	NULL
receptor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:3294	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Koeffler	NULL
HP	NULL
,	NULL
Chen	NULL
ISY	NULL
,	NULL
Golde	NULL
DW	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
novel	NULL
HTLV-infected	NULL
cell	NULL
line	NULL
.	NULL

Blood	NULL
64:482	NULL
,	NULL
1984	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1,25-DIHYDROXYVITAMIN	NULL
D	NULL
,	NULL
RECEPTOR	NULL
RNA	NULL
16	NULL
.	NULL

Pegoraro	NULL
L	NULL
,	NULL
Matera	NULL
L	NULL
,	NULL
Ritz	NULL
J	NULL
,	NULL
Levis	NULL
A	NULL
,	NULL
Palumbo	NULL
A	NULL
,	NULL
Biagini	NULL
G	NULL
:	NULL
Establishment	NULL
of	NULL
a	NULL
Ph'-positive	NULL
human	NULL
cell	NULL
line	NULL
(	NULL
BV173	NULL
)	NULL
.	NULL

J	NULL
Natl	NULL
Cancer	NULL
Inst	NULL
70:447	NULL
,	NULL
1983	NULL
17	NULL
.	NULL

Koeffler	NULL
HP	NULL
,	NULL
Gasson	NULL
J	NULL
,	NULL
Tobler	NULL
A	NULL
:	NULL
Transcriptional	NULL
and	NULL
post-transcriptional	NULL
modulation	NULL
of	NULL
myeloid	NULL
colony-stimulating	NULL
factor	NULL
expression	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
other	NULL
agents	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:3432	NULL
,	NULL
1988	NULL
18	NULL
.	NULL

Imaizumi	NULL
M	NULL
,	NULL
Breitman	NULL
TR	NULL
:	NULL
Retinoic	NULL
acid-induced	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
fresh	NULL
human	NULL
leukemia	NULL
cells	NULL
in	NULL
primary	NULL
culture	NULL
:	NULL
A	NULL
model	NULL
for	NULL
differentiation	NULL
inducing	NULL
therapy	NULL
of	NULL
leukemia	NULL
.	NULL

Eur	NULL
J	NULL
Hematol	NULL
38:289	NULL
,	NULL
1987	NULL
19	NULL
.	NULL

Rovera	NULL
G	NULL
,	NULL
O'Breine	NULL
TA	NULL
,	NULL
Diamond	NULL
L	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
in	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
tumor	NULL
promotors	NULL
.	NULL

Science	NULL
204:868	NULL
,	NULL
1979	NULL
20	NULL
.	NULL

Pennica	NULL
D	NULL
,	NULL
Nedwin	NULL
GE	NULL
,	NULL
Hayflick	NULL
JS	NULL
,	NULL
Seeburg	NULL
PH	NULL
,	NULL
Derynch	NULL
R	NULL
,	NULL
Palladino	NULL
MA	NULL
,	NULL
Kohl	NULL
WJ	NULL
,	NULL
Aggarwal	NULL
BB	NULL
,	NULL
Goeddel	NULL
DV	NULL
:	NULL
Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
:	NULL
Precursor	NULL
structure	NULL
,	NULL
expression	NULL
and	NULL
homol-ogy	NULL
to	NULL
lymphotoxin	NULL
.	NULL

Nature	NULL
312:724	NULL
,	NULL
1984	NULL
21	NULL
.	NULL

Maniatis	NULL
T	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Sambrook	NULL
J	NULL
:	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
1982	NULL
22	NULL
.	NULL

Clemens	NULL
MJ	NULL
:	NULL
Purification	NULL
of	NULL
eukaryotic	NULL
mRNA	NULL
,	NULL
in	NULL
Hames	NULL
BD	NULL
,	NULL
Higgins	NULL
SJ	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Transcription	NULL
and	NULL
Translation	NULL
,	NULL
Washington	NULL
,	NULL
IRI	NULL
Press	NULL
,	NULL
1984	NULL
,	NULL
p	NULL
211	NULL
23	NULL
.	NULL

Ponte	NULL
P	NULL
,	NULL
Gunning	NULL
P	NULL
,	NULL
Blau	NULL
H	NULL
,	NULL
Kedes	NULL
L	NULL
;	NULL
Human	NULL
actin	NULL
genes	NULL
are	NULL
single	NULL
copy	NULL
of	NULL
alpha-skeletal	NULL
and	NULL
alpha-cardiac	NULL
actin	NULL
but	NULL
multicopy	NULL
for	NULL
beta-	NULL
and	NULL
gamma-cytoskeletal	NULL
genes	NULL
:	NULL
3	NULL
'	NULL
Untranslated	NULL
regions	NULL
are	NULL
isotype	NULL
specific	NULL
but	NULL
conserved	NULL
in	NULL
evolution	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
3:1	NULL
783	NULL
,	NULL
1983	NULL
24	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
25	NULL
.	NULL

Wecksler	NULL
WR	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
A	NULL
hydroxylapatite	NULL
batch	NULL
assay	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
1	NULL
@	NULL
,	NULL
25	NULL
dihydroxyvitamin	NULL
D	NULL
;	NULL
-receptor	NULL
com-plex	NULL
.	NULL

Anal	NULL
Biochem	NULL
92:314	NULL
,	NULL
1979	NULL
26	NULL
.	NULL

Hunziker	NULL
W	NULL
,	NULL
Walters	NULL
MR	NULL
,	NULL
Bishop	NULL
JE	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
Effect	NULL
of	NULL
vitamin	NULL
D	NULL
status	NULL
on	NULL
the	NULL
equilibrium	NULL
between	NULL
occupied	NULL
and	NULL
unoccupied	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
intestinal	NULL
receptors	NULL
in	NULL
the	NULL
chick	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
69:826	NULL
,	NULL
1982	NULL
27	NULL
.	NULL

Linial	NULL
M	NULL
,	NULL
Gunderson	NULL
N	NULL
,	NULL
Groundine	NULL
M	NULL
:	NULL
Enhanced	NULL
transcription	NULL
of	NULL
MYC	NULL
in	NULL
bursal	NULL
lymphoma	NULL
cells	NULL
requires	NULL
continuous	NULL
protein	NULL
synthesis	NULL
.	NULL

Science	NULL
230:1216	NULL
,	NULL
1985	NULL
28	NULL
.	NULL

Koeffler	NULL
HP	NULL
,	NULL
Amatruda	NULL
T	NULL
,	NULL
Ikekawa	NULL
N	NULL
,	NULL
Kobayashi	NULL
Y	NULL
,	NULL
DeLuca	NULL
HF	NULL
:	NULL
Induction	NULL
of	NULL
macrophage	NULL
differentiation	NULL
of	NULL
human	NULL
normal	NULL
and	NULL
leukemic	NULL
myeloid	NULL
stem	NULL
cells	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
and	NULL
its	NULL
fluorinated	NULL
analogues	NULL
.	NULL

Cancer	NULL
Res	NULL
44:5624	NULL
,	NULL
1984	NULL
29	NULL
.	NULL

Tho	NULL
S	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
Kura	NULL
F	NULL
,	NULL
Sugiyama	NULL
H	NULL
,	NULL
Hoshino	NULL
T	NULL
:	NULL
The	NULL
effect	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
on	NULL
in	NULL
vitro	NULL
immunoglobulin	NULL
production	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
236:4427	NULL
,	NULL
1986	NULL
30	NULL
.	NULL

Rigby	NULL
WFC	NULL
,	NULL
Denome	NULL
S	NULL
,	NULL
Fanger	NULL
MW	NULL
:	NULL
Regulation	NULL
of	NULL
lympho-	NULL
1247	NULL
kine	NULL
production	NULL
and	NULL
human	NULL
T	NULL
lymphocyte	NULL
activation	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
:	NULL
Specific	NULL
inhibition	NULL
at	NULL
the	NULL
level	NULL
of	NULL
messenger	NULL
RNA	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
79:1659	NULL
,	NULL
1984	NULL
31	NULL
.	NULL

Tsoukas	NULL
CD	NULL
,	NULL
Provvedini	NULL
DM	NULL
,	NULL
Manolagas	NULL
SC	NULL
:	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
:	NULL
A	NULL
novel	NULL
immunoregulatory	NULL
hormone	NULL
.	NULL

Science	NULL
224	NULL
:	NULL
1438	NULL
,	NULL
1984	NULL
32	NULL
.	NULL

Reichel	NULL
H	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Tobler	NULL
A	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
1a	NULL
,	NULL
25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
inhibits	NULL
y-interferon	NULL
synthesis	NULL
by	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:3385	NULL
,	NULL
1987	NULL
33	NULL
.	NULL

Toblert	NULL
A	NULL
,	NULL
Millet	NULL
CW	NULL
,	NULL
Norman	NULL
AW	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
lymphokine	NULL
(	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
)	NULL
posttranscrip-tionally	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
81:1819	NULL
,	NULL
1988	NULL
34	NULL
.	NULL

Rosewicz	NULL
S	NULL
,	NULL
McDonald	NULL
AR	NULL
,	NULL
Maddux	NULL
BA	NULL
,	NULL
Goldfine	NULL
ID	NULL
,	NULL
Miesfeld	NULL
RL	NULL
,	NULL
Logsdon	NULL
CD	NULL
:	NULL
Mechanism	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
down-regulation	NULL
by	NULL
glucocorticoid	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
263:2581	NULL
,	NULL
1988	NULL
35	NULL
.	NULL

Costa	NULL
EM	NULL
,	NULL
Hirst	NULL
MA	NULL
,	NULL
Feldman	NULL
D	NULL
:	NULL
Regulation	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
receptors	NULL
by	NULL
vitamin	NULL
D	NULL
analogs	NULL
in	NULL
cultured	NULL
mammalian	NULL
cells	NULL
.	NULL

Endocrinology	NULL
117:2203	NULL
,	NULL
1985	NULL
36	NULL
.	NULL

Lee	NULL
Y	NULL
,	NULL
Inaba	NULL
M	NULL
,	NULL
DeLuca	NULL
H	NULL
,	NULL
Mellon	NULL
WS	NULL
:	NULL
Immunological	NULL
identification	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
(	NULL
HL-60	NULL
)	NULL
during	NULL
homologous	NULL
regula-tion	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:13701	NULL
,	NULL
1989	NULL
37	NULL
.	NULL

Provvedini	NULL
DM	NULL
,	NULL
Tsoukas	NULL
CD	NULL
,	NULL
Deftos	NULL
LJ	NULL
,	NULL
Manolagas	NULL
SC	NULL
:	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
receptors	NULL
in	NULL
human	NULL
leukocytes	NULL
.	NULL

Science	NULL
221:1181	NULL
,	NULL
1983	NULL
38	NULL
.	NULL

Lemire	NULL
JM	NULL
,	NULL
Adams	NULL
JS	NULL
,	NULL
Dermani-Arab	NULL
V	NULL
,	NULL
Bakke	NULL
AC	NULL
,	NULL
Sakai	NULL
R	NULL
,	NULL
Jordan	NULL
SC	NULL
:	NULL
1,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
suppresses	NULL
human	NULL
T	NULL
helper/inducer	NULL
lymphocyte	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Immunol	NULL
134:3032	NULL
,	NULL
1985	NULL
39	NULL
.	NULL

Koeffler	NULL
HP	NULL
,	NULL
Reichel	NULL
H	NULL
,	NULL
Bishop	NULL
JE	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
y-Interferon	NULL
stimulates	NULL
production	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
by	NULL
normal	NULL
human	NULL
macrophages	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
127:596	NULL
,	NULL
1985	NULL
40	NULL
.	NULL

Reichel	NULL
H	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
Synthesis	NULL
in	NULL
vitro	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
and	NULL
24,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
by	NULL
inter-feron-gamma-stimulated	NULL
normal	NULL
human	NULL
bone	NULL
marrow	NULL
and	NULL
alveolar	NULL
macrophages	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
262:10931	NULL
,	NULL
1987	NULL
41	NULL
.	NULL

Reichel	NULL
H	NULL
,	NULL
Koefflet	NULL
HP	NULL
,	NULL
Bishop	NULL
JE	NULL
,	NULL
Norman	NULL
AW	NULL
:	NULL
25-hydroxyvitamin	NULL
D	NULL
,	NULL
metabolism	NULL
by	NULL
lipopolysaccharide-stimulated	NULL
normal	NULL
human	NULL
macrophages	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
64:1	NULL
,	NULL
1987	NULL
42	NULL
.	NULL

Kizaki	NULL
M	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Lin	NULL
CW	NULL
,	NULL
Miller	NULL
CW	NULL
:	NULL
Expression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
mRNA	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Leuk	NULL
Res	NULL
14645	NULL
,	NULL
1990	NULL
43	NULL
.	NULL

Dani	NULL
C	NULL
,	NULL
Blanchard	NULL
JM	NULL
,	NULL
Piechaczyk	NULL
M	NULL
,	NULL
Sabouty	NULL
EI	NULL
,	NULL
Mary	NULL
L	NULL
,	NULL
Janteur	NULL
P	NULL
:	NULL
Extreme	NULL
instability	NULL
of	NULL
MYC	NULL
mRNA	NULL
in	NULL
normal	NULL
and	NULL
transformed	NULL
human	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:7046	NULL
,	NULL
1984	NULL
44	NULL
.	NULL

Greenberg	NULL
ME	NULL
,	NULL
Hermanowski	NULL
AL	NULL
,	NULL
Ziff	NULL
EB	NULL
:	NULL
Effect	NULL
of	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
on	NULL
growth	NULL
factor	NULL
activation	NULL
of	NULL
FOS	NULL
,	NULL
MYC	NULL
and	NULL
actin	NULL
gene	NULL
transcription	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
6:1050	NULL
,	NULL
1986	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1991	NULL
77	NULL
:	NULL
1238-1247	NULL
1,25-Dihydroxyvitamin	NULL
D3	NULL
receptor	NULL
RNA	NULL
:	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
ETY	NULL
Op	NULL
~	NULL
2	NULL
A	NULL
G	NULL
,	NULL
%	NULL
A	NULL
'	NULL
.	NULL

:	NULL
e	NULL
@	NULL
.	NULL

Â®	NULL
``	NULL
Oto	NULL
(	NULL
f	NULL
M	NULL
Kizaki	NULL
,	NULL
AW	NULL
Norman	NULL
,	NULL
JE	NULL
Bishop	NULL
,	NULL
CW	NULL
Lin	NULL
,	NULL
A	NULL
Karmakar	NULL
and	NULL
HP	NULL
Koeffler	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/77/6/1238.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

